cro.directory
← Compare landing

ACM Global Laboratories vs Fog City Bio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/acmgloballab/fogcitybio

CategoryACM Global LaboratoriesFog City Bio
Listed sitecrocro
SummaryGlobal clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.Specialized CRO for immunoassay development and optimization using Simoa, HTRF, AlphaLISA, Luminex, MSD ECL, and label-free kinetics platforms. Direct scientist engagement with rapid turnaround and handoff-ready protocols.
Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • LC-MS Bioanalysis (Small Molecule)
  • Biomarker Assays
  • Flow Cytometry Services
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Pathology & Histology Services
  • GLP Toxicology
  • Clinical Trial Services
  • Data Management & eClinical
  • Analytical Method Development & Validation
  • CMC Analytical Development
  • Analytical Method Development & Validation
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Radiopharmaceutical
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Rochester, NY, United States
  • Europe, York, UK
  • Asia, Singapore, Singapore
  • India, Mumbai, Maharashtra, India
  • Europe, York, United Kingdom
  • Headquarters, San Francisco, California, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.